Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael

Showing results (31-40 of 1,129) with videos related to

Pageof 113
Sort By:
Women'S Health (London, England)|June 24, 2015
Secondary fracture prevention via a Fracture Liaison ServiceE Michael Lewiecki
Developmental Psychology|September 9, 2010
The value of reanalysis and replication: introduction to special sectionE Michael Foster
Expert Opinion on Biological Therapy|December 1, 2010
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosisE Michael Lewiecki
American Family Physician|October 1, 2010
Bone density testing to monitor osteoporosis therapy in clinical practiceE Michael Lewiecki
Current Medical Research and Opinion|November 6, 2010
Clinical use of denosumab for the treatment for postmenopausal osteoporosisE Michael Lewiecki
Nature Clinical Practice. Endocrinology & Metabolism|August 25, 2006
Is alendronate therapy cost-effective for postmenopausal osteopenia?E Michael Lewiecki
Expert Opinion on Biological Therapy|September 23, 2006
RANK ligand inhibition with denosumab for the management of osteoporosisE Michael Lewiecki
Endocrinology and Metabolism Clinics of North America|May 23, 2021
Assessment of Skeletal Strength: Bone Density Testing and BeyondE Michael Lewiecki
Current Osteoporosis Reports|January 15, 2022
Evaluating Patients for Secondary Causes of OsteoporosisE Michael Lewiecki
Endocrinology and Metabolism (Seoul, Korea)|March 24, 2021
Operationalizing Treat-to-Target for OsteoporosisE Michael Lewiecki
Pageof 113

Showing results (31-40 of 1,129) with videos related to

Sort By:
Pageof 113
Women'S Health (London, England)|June 24, 2015
Secondary fracture prevention via a Fracture Liaison ServiceE Michael Lewiecki
Developmental Psychology|September 9, 2010
The value of reanalysis and replication: introduction to special sectionE Michael Foster
Expert Opinion on Biological Therapy|December 1, 2010
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosisE Michael Lewiecki
American Family Physician|October 1, 2010
Bone density testing to monitor osteoporosis therapy in clinical practiceE Michael Lewiecki
Current Medical Research and Opinion|November 6, 2010
Clinical use of denosumab for the treatment for postmenopausal osteoporosisE Michael Lewiecki
Nature Clinical Practice. Endocrinology & Metabolism|August 25, 2006
Is alendronate therapy cost-effective for postmenopausal osteopenia?E Michael Lewiecki
Expert Opinion on Biological Therapy|September 23, 2006
RANK ligand inhibition with denosumab for the management of osteoporosisE Michael Lewiecki
Endocrinology and Metabolism Clinics of North America|May 23, 2021
Assessment of Skeletal Strength: Bone Density Testing and BeyondE Michael Lewiecki
Current Osteoporosis Reports|January 15, 2022
Evaluating Patients for Secondary Causes of OsteoporosisE Michael Lewiecki
Endocrinology and Metabolism (Seoul, Korea)|March 24, 2021
Operationalizing Treat-to-Target for OsteoporosisE Michael Lewiecki
Pageof 113